Venture Capital

Silicon Valley’s money-making engine is stalled as technology start-ups find it harder to sell themselves or go public. Part of the blame, entrepreneurs and investors say, falls on the big investment banks. Even if a start-up ready to go public attracts the attention of the big...

For companies that go public, how do those that were backed primarily by angel investors fare against those primarily backed by venture capitalists? That was one of the questions addressed in a working paper recently published by two professors from the University of New Hampshire....

Wisconsin companies raised $6.5 million of venture capital funding in the first half of the year - a falloff of 81% from a year earlier, and the state's slowest start since 2005. The weak start mirrored a decline nationally. Venture capitalists invested $6.9 billion during the first half...

Biotech investor Steve Burrill is out raising a $1 billion fund to support the massive bioscience project planned for Elk Run, near Rochester, though he has “no checks yet.” Burrill plans to use half the proposed fund, or $500 million, to support construction of the 2,300-acre...

When companies start up, often the first place they look for seed financing is from friends and family. As frequently as they occur, there is very little available on the details of what consists of a “good” friends and family financing. In this...

Alnylam leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to rise. BioHealth Investor began by analyzing 171 stocks in the biotech sector based on revenue growth over the trailing four quarters, identifying 30 stocks in the sector with...

Biotechnology start-ups have long relied on grants from the National Institutes of Health to fund the research-and-development process for new drugs, medical devices and disease treatments. Every year, the agency is required by law to set aside 2.8 percent of its research budget -- $650...